Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Topical Drugs Contract Development And Manufacturing Organization CDMO Market Report 2024

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 – By Product Type (Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products), By Service Type (Contract Development, Contract Manufacturing), By Therapeutic Area (Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas), By End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses) – Market Size, Trends, And Global Forecast 2025-2034

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Definition

A topical drugs contract development and manufacturing organization (CDMO) is a specialized company that provides comprehensive services for the development, formulation, and production of topical pharmaceuticals. These services include research and development, clinical trial material production, and commercial manufacturing. CDMOs help pharmaceutical companies bring topical drug products to market efficiently and compliantly.

The main product types of topical drug contract development and manufacturing organization (CDMO) are semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations include creams, ointments, gels, and pastes designed for topical application. Various service types include contract development, contract manufacturing for a variety of therapeutic areas such as Dermatology, Pain Management, wound care, and ophthalmology, and others. These are used by different end-uses, which include pharmaceutical companies, biopharmaceutical companies, and others.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmentation

The topical drugs contract development and manufacturing organization (CDMO) market covered in this report is segmented –

1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products

2) By Service Type: Contract Development, Contract Manufacturing

3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas

4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses

Subsegments:

1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes

2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions

3) By Solid Formulations: Powders, Tablets

4) By Transdermal Products: Patches

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size and growth rate 2025 to 2029: Graph

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size 2025 And Growth Rate

The topical drugs contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $52.9 billion in 2024 to $61.69 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to chronic disease prevalence, advanced drug delivery technologies, cost-efficient outsourcing, regulatory demands, and growth in dermatology and cosmetics.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Forecast

The topical drugs contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $113.06 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to personalized medicine, biologics expansion, increased R and D investments, rising skin disorder prevalence, and advanced manufacturing technologies. Major trends in the forecast period include increasing demand for innovative formulations, advancements in drug delivery technologies, rising investment in dermatological research, a surge in outsourcing by pharmaceutical companies, a focus on personalized medicine, stringent regulatory requirements necessitating specialized expertise, and the growing consumer preference for over-the-counter (OTC) skincare products.

Book your 30 minutes free consultation with our research experts

Contact Us

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Driver: Rising Skin Disease Prevalence Fuels Growth In The Topical Drugs CDMO Market

The increasing prevalence of skin diseases is expected to propel the growth of the topical drugs contract development and manufacturing organization (CDMO) market going forward. Skin diseases refer to medical conditions that affect the skin, causing symptoms such as inflammation, itching, and lesions. The increasing prevalence of skin diseases can be attributed to factors such as environmental pollution, UV radiation exposure, genetic predisposition, lifestyle changes, and microbial infections. Topical drugs contract development and manufacturing organization (CDMO) helps reduce skin disease prevalence by developing and manufacturing targeted therapies that improve the management and treatment of dermatological conditions. For instance, in January 2024, according to Cancer Australia, an Australian-based cancer control agency, Australia saw a significant increase in skin melanoma cases between 2019 and 2023, with numbers rising from 15,628 to 18,257. Furthermore, in 2019, males had 9,134 cases compared to 6,494 females, while by 2023, the proportions had risen to 10,639 males and 7,618 females. Therefore, the increasing prevalence of skin diseases is driving the growth of the topical drugs contract development and manufacturing organization (CDMO) market.

Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Major Players

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd., Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.

Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trend: Focus On State-of-the-Art Manufacturing Facilities In The Topical Drugs CDMO Market

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are focused on developing state-of-the-art manufacturing facilities to sustain their position in the market. A state-of-the-art manufacturing facility is a specialized production site equipped with the latest technology and advanced processes tailored for the development and manufacturing of topical pharmaceutical products. For instance, in November 2023, SOHM Inc., a US-based pharmaceutical company, launched a CDMO GMP manufacturing facility. The new Carlsbad facility will offer ample space for manufacturing topical products and SOHM's operations, with 2,500 square feet dedicated to storing finished products. Initially, IT will have a daily capacity of 500 gallons (1,892 liters) for manufacturing topicals. By the end of Q1 2024 or the start of Q2 2024, IT is expected to expand its capacity to include soft-gel suppositories.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Merger And Acquisition: Corerx Inc. Acquires Catalent Inc. To Strengthen CDMO Capabilities And Expand Market Share

In April 2024, CoreRx Inc., a US-based pharmaceutical company, acquired Societal CDMO Inc. for $130 million. The acquisition is set to enhance CoreRx into a stronger CDMO, expanding its services from early-stage development to commercial manufacturing. It will streamline operations, increase market share, and provide long-term benefits such as improved economies of scale, better R&D, and a stronger competitive position. Societal CDMO Inc. is a US-based contract development and manufacturing organization that specializes in developing and manufacturing novel drug delivery formulations.

Regional Outlook For The Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2024. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?

The topical drugs contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as commercial manufacturing, research and development (R&D), regulatory support, and product lifecycle management. The market value includes the value of related goods sold by the service provider or included within the service offering. The topical drugs contract development and manufacturing organization (CDMO) market also includes sales of creams, ointments, gels, and lotions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Industry?

The topical drug contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides topical drug contract development and manufacturing organization (CDMO) market statistics, including topical drug contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a topical drug contract development and manufacturing organization (CDMO) market share, detailed topical drug contract development and manufacturing organization (CDMO) market segments, market trends and opportunities, and any further data you may need to thrive in the topical drug contract development and manufacturing organization (CDMO) industry. This topical drug contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $61.69 billion
Revenue Forecast In 2034 $113.06 billion
Growth Rate CAGR of 16.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses Subsegments: 1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders, Tablets
4) By Transdermal Products: Patches
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd, Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Characteristics

    3. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

    4. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

    5.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis

    5.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

    6. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmentation

    6.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Semi-Solid Formulations

    Liquid Formulations Drugs

    Solid Formulations

    Transdermal Products

    6.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Contract Development

    Contract Manufacturing

    6.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Dermatology

    Pain Management

    Wound Care

    Ophthalmology

    Other Therapeutic Areas

    6.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Pharmaceutical Companies

    Biopharmaceutical Companies

    Other End-Uses

    6.5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Creams

    Ointments

    Gels

    Pastes

    6.6. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Solutions

    Suspensions

    Emulsions

    Lotions

    6.7. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Powders

    Tablets

    6.8. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Patches

    7. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

    7.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    8.1. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    9.1. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    9.2. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    10.1. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    11.1. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    11.2. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    12.1. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    13.1. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    14.1. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    14.2. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    15.1. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    15.2. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    16.1. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    17.1. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    18.1. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    19.1. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    20.1. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    21.1. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    21.2. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    22.1. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    23.1. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    23.2. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    24.1. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    24.2. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    25.1. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    25.2. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    26.1. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    26.2. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    27.1. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    28.1. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    28.2. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    29.1. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

    29.2. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

    30.1. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape

    30.2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Company Profiles

    30.2.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. SGS SA Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. The Lubrizol Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

    31. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

    31.1. Catalent Inc.

    31.2. Bora Pharmaceuticals Co. Ltd.

    31.3. Recipharm AB

    31.4. Pierre Fabre S.A.

    31.5. Piramal Pharma Solutions

    31.6. Cambrex Corporation

    31.7. LTS Lohmann Therapie-Systeme AG

    31.8. PCI Pharma Services

    31.9. Famar S.A.

    31.10. Contract Pharmaceuticals Limited

    31.11. UPM Pharmaceuticals Inc.

    31.12. CoreRx Inc.

    31.13. Halo Pharmaceutical Inc.

    31.14. Tapemark Company

    31.15. Groupe PARIMA Inc.

    32. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    34. Recent Developments In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

    35. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

    35.1 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities

    35.2 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities

    35.3 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Evonik Industries AG Financial Performance
  • Table 80: Eurofins Scientific SE Financial Performance
  • Table 81: SGS SA Financial Performance
  • Table 82: The Lubrizol Corporation Financial Performance
  • Table 83: Lonza Group AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Evonik Industries AG Financial Performance
  • Figure 80: Eurofins Scientific SE Financial Performance
  • Figure 81: SGS SA Financial Performance
  • Figure 82: The Lubrizol Corporation Financial Performance
  • Figure 83: Lonza Group AG Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the oncology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the filgrastim biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Topical Drug Delivery Global Market Report 2025 – By Product Type (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), By Route Of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), By End User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Topical Pain Relief Global Market Report 2025 – By Type (Prescription Pain Relief, Over-The-Counter (OTC) Pain Relief), By Formulation (Cream, Gel, Spray, Patch, Other Formulations), By Therapeutic (Non-Opioids, Opioids), By Distribution Channel (Pharmacies And Drug Stores, E-Commerce, Retail And Grocery Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Synthesis Global Market Report 2025 – By Product And Service (Reagents, Equipment, Services), By Technology (Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology), By End User (Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biosimilar Therapeutic Peptides Global Market Report 2025 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Therapeutics Global Market Report 2025 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Penetrating Peptide Global Market Report 2025 – By Type (Synthetic Cell Penetrating Peptides, Protein-Derived Cell Penetrating Peptides, Chimeric Cell Penetrating Peptides), By Application (Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, Other Applications), By End Use (Pharmaceutical And Biotechnology Companies, Contract Research Organization (CROs), Hospitals And Clinics, Others End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Narcotic Drugs Global Market Report 2025 – By Drug (Opium, Heroin, Codeine, Oxycodone, Other Drugs), By Source (Natural, Semi-Synthetic, Synthetic), By Indication (Pain Management, Cough, Diarrhea, Dysentery, Asthma, Other Indications), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2025 – By Type (Losmapimod, SHP-627, Sparsentan, TM-5484, Other Types), By Treatment (Corticosteroids, Immunosuppressive Drugs, Angiotensin Converting Enzymes (ACE) Inhibitors, A.R. Blockers, Diuretics, Other Treatments), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market?

A topical drugs contract development and manufacturing organization (CDMO) is a specialized company that provides comprehensive services for the development, formulation, and production of topical pharmaceuticals. These services include research and development, clinical trial material production, and commercial manufacturing. CDMOs help pharmaceutical companies bring topical drug products to market efficiently and compliantly. For further insights on the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market, request a sample here

How will the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market drivers and restraints affect the market dynamics? What forces will shape the Topical Drugs Contract Development And Manufacturing Organization (CDMO) industry go

The Topical Drugs Contract Development And Manufacturing Organization (CDMO) market major growth driver - Rising Skin Disease Prevalence Fuels Growth In The Topical Drugs CDMO Market. For further insights on the Topical Drugs Contract Development And Manu request a sample here

What is the forecast market size or the forecast market value of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market?

The Topical Drugs Contract Development And Manufacturing Organization (CDMO) market size has grown strongly in recent years. The topical drugs contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $52.9 billion in 2024 to $61.69 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to chronic disease prevalence, advanced drug delivery technologies, cost-efficient outsourcing, regulatory demands, and growth in dermatology and cosmetics. The topical drugs contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $113.06 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to personalized medicine, biologics expansion, increased R and D investments, rising skin disorder prevalence, and advanced manufacturing technologies. Major trends in the forecast period include increasing demand for innovative formulations, advancements in drug delivery technologies, rising investment in dermatological research, a surge in outsourcing by pharmaceutical companies, a focus on personalized medicine, stringent regulatory requirements necessitating specialized expertise, and the growing consumer preference for over-the-counter (OTC) skincare products. For further insights on the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market, request a sample here

How is the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market segmented?

The topical drugs contract development and manufacturing organization (CDMO) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders, Tablets
4) By Transdermal Products: Patches For further insights on the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market, request a sample here

Which region has the largest share of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2023. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

Who are the major players in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market?

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are focused on developing state-of-the-art manufacturing facilities to sustain their position in the market. A state-of-the-art manufacturing facility is a specialized production site equipped with the latest technology and advanced processes tailored for the development and manufacturing of topical pharmaceutical products. For instance, in November 2023, SOHM Inc., a US-based pharmaceutical company, launched a CDMO GMP manufacturing facility. The new Carlsbad facility will offer ample space for manufacturing topical products and SOHM's operations, with 2,500 square feet dedicated to storing finished products. Initially, it will have a daily capacity of 500 gallons (1,892 liters) for manufacturing topicals. By the end of Q1 2024 or the start of Q2 2024, it is expected to expand its capacity to include soft-gel suppositories.. For further insights on the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

What are the key trends in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market?

Major trends in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market include Focus On State-of-the-Art Manufacturing Facilities In The Topical Drugs CDMO Market. For further insights on the Topical Drugs Contract Development request a sample here.

What are the major opportunities in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market? What are the strategies for the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market?

For detailed insights on the major opportunities and strategies in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

How does the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market relate to the overall economy and other similar markets?

For detailed insights on Topical Drugs Contract Development And Manufacturing Organization (CDMO)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) industry?

For detailed insights on the mergers and acquisitions in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) industry, request a sample here.

What are the key dynamics influencing the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market growth? SWOT analysis of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market.

For detailed insights on the key dynamics influencing the Topical Drugs Contract Development And Manufacturing Organization (CDMO) market growth and SWOT analysis of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) industry, request a sample here.